Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In a bid to enhance the supply of Carbon Monoxide (CO), specialty chemical company Air Products & Chemicals Inc. ( APD - Analyst Report ) signed an agreement with world’s leading chemical company BASF for expanding its Syngas Separation Unit (SSU) in Geismar, Louisiana. The increased CO production will serve BASF’s upcoming large-scale formic acid plant at the Geismar Verbund site.
The expansion of the Syngas facility will enable Air Products to produce more hydrogen for refinery and petrochemical customers along its vast Gulf Coast hydrogen pipeline network system. The expanded facility will also help in filling CO from the existing Geismar transfill facility. It is expected to come online in the second quarter of 2014.
Air Products is the world’s leading supplier of hydrogen for processing cleaner burning transportation fuels and hydrogen infrastructure and fueling technology. The company currently fuels over 1,000 pieces of material handling equipment on a daily basis in the U.S. The company is a leading supplier in liquefied natural gas technology and equipments industry.
The company reported adjusted (excluding one-time items) earnings from continued operations of $1.41 a share for the third quarter of 2012, in line with the Zacks Consensus Estimate. Consolidated net income surged 48% year over year to $484.5 million or $2.26 a share compared with $326.5 million or $1.50 a year ago. The increase in profits was attributable to lower costs, which more than offset the impact of lower sales.
Revenues dipped 5% year over year to $2,340.1 million in the quarter, missing the Zacks Consensus Estimate of $2,455 million. Challenging conditions in Europe and Asia as well as unfavorable currency weighed on the company’s top line in the quarter.
Air Products’ healthy project backlog and solid bidding activity strongly positions it to achieve its long-term growth target. Given its leading position in the gases business, the company is well positioned to capitalize on the cyclical recovery in its core industrial end markets. Further, new business deals are expected to boost profits in 2012. However, soaring energy and raw material costs are likely to hamper margins.
Air Products, which competes with Praxair Inc. ( PX - Analyst Report ) , currently retains a Zacks #4 Rank, which translates into a short-term (1 to 3 months) Sell rating. We have a long-term (more than 6 months) Neutral recommendation on the stock.
Read the full reports :
Analyst Report on PX
Analyst Report on APD